Transcenta Holding Limited 創勝集團醫藥有限公司
Main board
| Name | ⚥ | Age in 2024 |
Position | From | Until | |
|---|---|---|---|---|---|---|
| 1 | Bao, Jun (Impact Therapeutics) 包駿 | M | 57 | INEDIndependent Non-Executive Director | 2021-09-14 | 2023-08-23 |
| 2 | Chen, Helen Wei 陳瑋 | F | 57 | INEDIndependent Non-Executive Director | 2023-08-23 | |
| 3 | Qian, Xueming 錢雪明 | M | 56 | CEOChief Executive Officer | 2012-10-18 | |
| 4 | Shi, Michael Ming 石明 | M | 58 | EDExecutive Director | 2021-03-31 | 2022-07-20 |
| 5 | Srinivasan, Kumar | M | 60 | INEDIndependent Non-Executive Director | 2022-12-19 | |
| 6 | Tang, Jiasong 唐稼松 | M | 50 | INEDIndependent Non-Executive Director | 2021-09-14 | |
| 7 | Weng, Xiaolu 翁曉路 | M | 48 | FDFinance Director | 2022-03-21 | 2024-04-30 |
| 8 | Zhang, Zhihua (1982) 張志華 | M | 42 | INEDIndependent Non-Executive Director | 2021-09-14 | |
| 9 | Zhao, Jonathan Yining 趙奕寧 | M | 52 | NED, ChNon-Executive Director, Chairman | 2018-12-01 | |
| 10 | Zhu, Albert Da 朱達 | M | 43 | EDExecutive Director | 2021-03-31 | 2022-06-26 |
Manager/adviser/other
| Name | ⚥ | Age in 2024 |
Position | From | Until | |
|---|---|---|---|---|---|---|
| 1 | Leung, Kwan Wai (1981) 梁君慧 | F | 43 | CoSecCompany Secretary | ||
| 2 | Weng, Xiaolu 翁曉路 | M | 48 | CFOChief Financial Officer | 2021-12-17 | 2022-03-21 |
| CFOChief Financial Officer | 2024-04-30 | |||||
| 3 | Zhu, Albert Da 朱達 | M | 43 | CoSecCompany Secretary | 2022-06-26 | |
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy